Female Reproductive Hormones — Exam Notes

Anatomy and overview of female hormones

• Females have two ovaries, one on each side of the uterus; ovaries contain ova (eggs).

• Ovaries secrete the female hormones estrogen and progesterone.

  • Estrogen promotes uterine, breast, and vaginal development.

  • Progesterone is involved in implantation/maintenance of pregnancy after fertilization.

• Anatomy connections (for orientation): ovary → fallopian tube → uterus; other ovary and tube on the opposite side.

• Each ovary contains primary follicles which house eggs; these follicles develop over the cycle.

• A follicle grows until mid-cycle when it ruptures (ovulation) releasing the oocyte into the fallopian tube for potential fertilization.

• After ovulation, the ruptured follicle degenerates into the corpus luteum, which primarily produces progesterone to support implantation and early pregnancy.

• If fertilization does not occur, the corpus luteum degenerates, progesterone falls, and menstruation occurs.

• Puberty and hormonal feedback:

  • Before puberty, adrenal estrogens can suppress pituitary LH/FSH release.

  • At puberty, estrogen levels rise, LH and FSH are released, and menstruation begins.

Follicular development and menstrual cycle phases

• Day 1 = first day of menstrual bleeding; marks the start of the follicular phase.

• Follicular phase:

  • Primary follicle develops into secondary follicle; oocyte inside grows.

  • Estrogen produced by the growing follicle increases during this phase.

• Ovulation (mid-cycle):

  • Triggered by a surge in Luteinizing Hormone (LH) due to rising estrogen.

  • The oocyte is released from the follicle into the fallopian tube.

• Luteal phase:

  • The remaining follicle becomes the corpus luteum, producing progesterone predominantly.

• Summary of phases: Follicular phase → Ovulation → Luteal phase.

• In terms of hormonal drivers:

  • Follicle growth is driven by FSH; estrogen rises as follicles grow.

  • LH surge triggers ovulation.

  • After ovulation, progesterone rises due to the corpus luteum.

Hormone level dynamics across the cycle

• Day 1: low levels of estrogen and progesterone; ovaries begin to cycle.

• Follicular phase:

  • Estrogen rises as follicles mature.

  • LH and FSH levels begin to rise; estrogen contributes to LH surge readiness.

• Around mid-cycle (ovulation):

  • Marked LH surge occurs, leading to ovulation.

  • FSH also rises but LH surge is the key trigger for ovulation.

• Luteal phase:

  • Corpus luteum secretes progesterone (and some estrogen).

  • Progesterone rises, supporting the endometrium for potential implantation.

  • If fertilization does not occur, progesterone falls as the corpus luteum degenerates, and other hormones decline, leading to menstruation and a new cycle.

• If fertilization occurs:

  • Human chorionic gonadotropin (hCG) is produced by the developing embryo to maintain the corpus luteum, sustaining progesterone production until placental takeover.

• Pregnancy-specific hormone timeline:

  • hCG detectable 8–11 days post-conception.

  • Around 3 weeks after the last menstrual period (LMP), hCG levels are typically between $5\text{ to }50\ \text{mIU/mL}$.

  • First-trimester hCG levels peak; placenta takes over progesterone and estrogen production after the first trimester, allowing hCG to decline.

• LMP terminology: LMP stands for last menstrual period; pregnancy timelines are often described relative to LMP.

• Menstrual cycle length and milestones:

  • First trimester roughly ends at about $12\ \text{weeks}$.

  • Ovulation occurs around mid-cycle; progesterone rises after ovulation.

Hormonal regulation and feedback loops

• Hypothalamic-pituitary-ovarian (HPO) axis:

  • Hypothalamus releases GnRH (gonadotropin-releasing hormone).

  • GnRH stimulates the pituitary to release FSH and LH.

  • FSH stimulates follicle growth; estrogen is produced by the follicle.

  • LH surge triggers ovulation and later supports the corpus luteum making progesterone.

• Negative feedback loops:

  • Low levels of estrogen and progesterone stimulate the hypothalamus to release GnRH, which increases FSH and LH (negative feedback/regulation).

  • After the LH surge and ovulation, rising progesterone (and estrogen) provides negative feedback to suppress GnRH, FSH, and LH to prevent additional follicle recruitment.

• Positive feedback loop (mid-cycle LH surge):

  • Rising estrogen from the mature follicle exerts a positive feedback on the hypothalamus/pituitary to promote a surge in LH (and some FSH), leading to ovulation.

• Tissue targets and outputs:

  • Follicle produces estrogen; corpus luteum produces progesterone.

  • The balance and timing of estrogen and progesterone determine endometrial preparation and feedback on the axis.

• Pregnancy maintenance via hCG:

  • Embryo-derived hCG keeps the corpus luteum functional, maintaining progesterone production to sustain the gestational endometrium until placental takeover.

Pregnancy and placental transition

• If the oocyte is fertilized and implants:

  • The developing embryo secretes hCG, which maintains the corpus luteum.

  • Progesterone remains high to maintain the endometrium and pregnancy.

• Placental takeover:

  • By the end of the first trimester, the placenta begins producing progesterone and estrogen, allowing hCG levels to decline.

• hCG diagnostic timeline:

  • Detectable 8–11 days post conception; rises during the first trimester and then levels off as placental production takes over.

Menopause and aging of the reproductive system

• Menopause definition: absence of menstrual cycles for at least $12\text{ months}$, indicating cessation of ovarian egg supply.

• Hormonal changes at menopause:

  • Estrogen and progesterone levels decline markedly.

  • FSH and LH levels rise to their highest levels during menopause due to reduced negative feedback.

• Symptoms and risks associated with menopause:

  • Hot flashes, fatigue, mood changes, anxiety, shortness of breath, abnormal vaginal bleeding may occur before cycles stop.

  • Long-term effects include decreased libido, osteoporosis, and increased risk of coronary artery disease.

• Hormone sources post-menopause:

  • No ovarian estrogen/progesterone production; risk profile changes due to depletion of endogenous hormones.

Estrogen and its widespread roles

• Estrogen (estradiol) roles:

  • Promotes maturation and maintenance of female reproductive organs; supports puberty development.

  • Stimulates oocyte maturation and assists in development of secondary sexual characteristics (breast development, hair growth patterns, fat distribution).

  • Maintains normal menstrual cycles and widens the pelvis for birth.

  • Can be produced in excess in males (rare) leading to gynecomastia and potential clotting risk due to negative feedback on FSH/LH and downstream testosterone reduction.

• Estrogen in pregnancy:

  • Supports uterine and fetal development and maternal tissue changes required for gestation.

Progesterone and its roles

• Progesterone roles:

  • Regulates the menstrual cycle and prepares the breast for lactation.

  • Raises basal body temperature a few hours after ovulation; used in fertility tracking to indicate ovulation timing.

  • Maintains the endometrium for implantation and early pregnancy.

• Progesterone in fertility tracking:

  • The rise in body temperature after ovulation is a clinical cue that ovulation has occurred and the luteal phase is underway.

Abnormalities of female reproductive function

• Hypogonadism (decreased female sex hormones)

  • Primary hypogonadism: problem with the ovaries leading to reduced estrogen/progesterone output; high FSH and LH due to loss of negative feedback.

  • Turner syndrome: a primary hypogonadism condition (monosomy X) in which individuals have only one X chromosome; features include short stature, neck webbing, infertility, and cardiac issues; inability to ovulate and secrete E2.

  • Other: incomplete or absent gonad development, inflammation (infection), autoimmune contributions, surgery, radiation, chemotherapy, enzyme deficiencies.

• Secondary hypogonadism (pituitary origin):

  • Decreased FSH/LH due to pituitary issues (e.g., Sheehan syndrome after postpartum hemorrhage; severe illness, malnutrition, anorexia, bulimia, stress) leading to decreased estrogen/progesterone.

• Hypergonadism (increased sex hormones)

  • Primary hypergonadism: ovarian origin; increased estrogen and progesterone with decreased FSH/LH due to negative feedback.

  • Secondary hypergonadism: pituitary origin; increased FSH/LH with increased estrogen/progesterone due to positive feedback; GnRH dynamics depend on feedback loops.

• Polycystic ovarian disease (PCOS)

  • Hormonal imbalance, especially LH/FSH ratio disturbances; ovaries become filled with immature follicles, forming polycysts.

  • Increased risk for cardiovascular disease and endometrial (uterine) cancer; infertility due to anovulation; hirsutism, acne; weight issues common. Possible androgen-producing ovarian tumors can cause virilization and masculinization.

• Hydatidiform mole (molar pregnancy)

  • Abnormal pregnancy where cells form in the uterus producing hCG; can mimic pregnancy clinically; ultrasound shows grape-like clusters.

Laboratory analysis of reproductive hormones

• LH and FSH testing

  • Can be measured in both sexes; used to distinguish primary vs secondary disorders.

  • Highest levels occur during menopause.

  • LH is used to predict ovulation due to the mid-cycle LH surge.

  • PCOS pattern often shows a higher LH relative to FSH (LH:FSH ratio > 2:1).

• Testosterone and DHEA

  • Male sex hormones; typically not measured in females unless masculinization is suspected or when evaluating PCOS; assess hypogonadism in males as well.

  • Elevated levels can indicate masculinization or androgen-secreting tumors.

• Estrogens

  • Assessed to identify ovarian estrogen function; high levels can indicate estrogen excess (e.g., in pregnancy, estrogen-secreting conditions) or ovarian hyperfunction.

  • Low levels may indicate ovarian hypo-function or menopause.

• Progesterone

  • Elevated during pregnancy and around ovulation; reflects corpus luteum function and luteal phase integrity.

  • Used in infertility workups to assess ability to maintain pregnancy; low levels may indicate luteal phase deficiency.

• Prolactin

  • Evaluates infertility or lactation issues; low prolactin is not typically the focus, but high prolactin can suppress GnRH and disrupt cycles.

  • Increased prolactin can cause inappropriate lactation or amenorrhea (absence of menses).

Practical implications and clinical correlations

• Infertility workups often involve tracking LH surge and progesterone rise to confirm ovulation; PCOS workups focus on LH:FSH ratios and ovarian morphology.

• Menopause-related risk management includes addressing hot flashes, mood changes, osteoporosis risk, and cardiovascular risks due to estrogen deficiency.

• Hormone therapy considerations: estrogen-progesterone balance affects clotting risk and metabolic health; excessive estrogen in males can cause gynecomastia and hormonal disruption.

• Awareness of ovarian tumors (e.g., androgen-producing tumors) and molar pregnancies is important in differential diagnoses when signs of hormonal imbalance or abnormal bleeding occur.

Summary for exam-ready concepts

• The ovarian cycle consists of follicular development, ovulation, and luteal phase, tightly regulated by FSH and LH with estrogen and progesterone mediating feedback.

• The LH surge around mid-cycle is essential for ovulation; estrogen exerts a temporary positive feedback to trigger this surge.

• The corpus luteum secretes progesterone to prepare and maintain the endometrium; hCG from a developing embryo preserves the corpus luteum in early pregnancy.

• Pregnancy is detectable by hCG approximately 8–11 days post-conception; hCG rises in the first trimester and plateaus as placental steroid production takes over.

• Menopause involves cessation of menses for at least $12\text{ months}$ with high FSH/LH and low estrogen/progesterone, along with a distinct symptom and risk profile.

• Estrogen and progesterone have wide-ranging roles in development, fertility, menstrual cycles, and secondary sex characteristics; dysregulation leads to common reproductive disorders.

• Core pathologies include primary vs secondary hypogonadism, Turner syndrome, Sheehan syndrome, PCOS, hypergonadism, hydatidiform mole.

• Key lab markers include LH/FSH (diagnostic for primary vs secondary issues; menopause marker; ovulation predictor), testosterone and DHEA (androgen status), estrogens, progesterone, and prolactin (fertility and lactation signals).

If you have questions on any of these topics, consider reaching out for clarification and review resources.